Intco Medical Technology Co., Ltd. (SHE:300677)
China
· Delayed Price · Currency is CNY 48.61
+2.90 (6.34%)
At close: Mar 9, 2026
Intco Medical Technology Revenue
Intco Medical Technology had revenue of 2.51B CNY in the quarter ending September 30, 2025, a decrease of -2.90%. This brings the company's revenue in the last twelve months to 9.85B, up 9.74% year-over-year. In the year 2024, Intco Medical Technology had annual revenue of 9.52B with 37.65% growth.
Revenue (ttm)
9.85B
Revenue Growth
+9.74%
P/S Ratio
3.20
Revenue / Employee
896.88K
Employees
10,982
Market Cap
31.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.52B | 2.60B | 37.65% |
| Dec 31, 2023 | 6.92B | 304.91M | 4.61% |
| Jan 1, 2023 | 6.61B | -9.63B | -59.27% |
| Jan 1, 2022 | 16.24B | 2.40B | 17.37% |
| Dec 31, 2020 | 13.84B | 11.75B | 564.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| iRay Group | 2.30B |
| Zhende Medical | 4.32B |
| Gan & Lee Pharmaceuticals. | 3.85B |
| Imeik Technology Development | 2.52B |
| Andon Health | 1.57B |
| Winner Medical | 10.80B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |